R1 RCM — Accretive Health — Q1 2016 Earnings Presentation
21 slides from R1 RCM's earnings presentation, May 10, 2016
Slide 1: Q1'16 Financial Results Conference Call
©2016 Accretive Health Inc.1 Q1’16 Financial Results Conference Call Exhibit 99.2 EDITABLE CONTENT May 10, 2016
Slide 2: Safe Harbor
©2016 Accretive Health Inc.2 Safe Harbor This presentation contains forward-looking statements, including statements regarding future growth, plans and performance. All forward-looking statements contained in this presentation involve risks and uncertainties. The Company’s actual results and outcome
Slide 3: Emad Rizk, M.D., Chief Executive Officer
©2016 Accretive Health Inc.3 Emad Rizk, M.D. Chief Executive Officer
Slide 4: 2016 Priorities
©2016 Accretive Health Inc.4 2016 Priorities 1) Continue to execute on operational excellence goals and product development plan 2) Onboard new Ascension business 3) Diversify customer base by growing non-Ascension footprint
Slide 5: Q1 Results and 2016 Views
©2016 Accretive Health Inc.5 Q1 Results and 2016 Views square4 2016 is likely to be a challenging year, driven by two main reasons: 1) Customer losses in 2015 2) Upfront investments and costs associated with onboarding Ascension square4 We are evaluating our cost structure to align with current busi
Slide 6: Longer-Term Views
©2016 Accretive Health Inc.6 Longer-Term Views square4 Company is well-positioned due to: 1) Competitive operating capabilities, including domestic and offshore shared services 2) Scalable infrastructure 3) Domain experience in large-scale outsourced RCM 4) Strong balance sheet square4 We will conti
Slide 7: Joe Flanagan, President & Chief Operating Officer
©2016 Accretive Health Inc.7 Joe Flanagan President & Chief Operating Officer
Slide 8: Accretive Health Operating System
©2016 Accretive Health Inc.8 Accretive Health Operating System square4 Designed to focus on areas that have the highest correlation to our customers’ revenue cycle performance square4 Important for three reasons: 1) Clearly communicate value proposition 2) Remove variation in results 3) Create a sta
Slide 9: President Role - Focus Areas
©2016 Accretive Health Inc.9 President Role - Focus Areas square4 Three focus areas in expanded role as President: 1) Drive cross-functional efficiencies between Operations, HR and IT Goal: Make our scaling capability a competitive advantage 2) Rapidly translate operational findings from on-site tea
Slide 10: Ascension Deployment Update
©2016 Accretive Health Inc.10 Ascension Deployment Update square4 Dedicated Deployment Office in place: 1) Fully resourced and functioning 2) Designed as a strategic function, able to scale and support simultaneous implementations across multiple customers 3) Established four pillars with defined ou
Slide 11: Chris Ricaurte, Chief Financial Officer & Treasurer
©2016 Accretive Health Inc.11 Chris Ricaurte Chief Financial Officer & Treasurer
Slide 12: Non-GAAP Measures
©2016 Accretive Health Inc.12 Non-GAAP Measures* Gross Cash Generated from Customer Contracting Activities GAAP revenue plus change in deferred customer billings Net Cash Generated from Customer Contracting Activities GAAP net income less interest, taxes, depreciation and amortization expense, share
Slide 13: 1Q'16 vs. 1Q'15 Results (non-GAAP)
©2016 Accretive Health Inc.13 1Q’16 vs. 1Q’15 Results (non-GAAP) ($ in millions) 1Q’16 1Q’15 y/y chg. Key change driver(s) Gross Cash Generated $40.9 $54.9 (25.6%) • Customer attrition • Pending contract renewal and transition to fixed-fee arrangements Cost of Services $41.0 $39.3 4.4% • Higher shar
Slide 14: 2016 Views
©2016 Accretive Health Inc.14 2016 Views square4 For the full year 2016 relative to 2015, we expect our top line: 1) To be pressured by $40-50 million due to prior customer losses, changes in scope, and customer renewals 2) To benefit by $20-30 million, given our current onboarding plan for Ascensio
Slide 15: Questions and Answers
©2016 Accretive Health Inc.15 Questions and Answers
Slide 16: Appendix
©2016 Accretive Health Inc.16 Appendix
Slide 17: Use of Non-GAAP Financial Measures
©2016 Accretive Health Inc.17 Use of Non-GAAP Financial Measures In order to provide a more comprehensive understanding of the information used by Accretive Health’s management team in financial and operational decision making, the Company supplements its GAAP consolidated financial statements with
Slide 18: Reconciliation of GAAP revenue to non-GAAP Gross Cash Generated
©2016 Accretive Health Inc.18 Reconciliation of GAAP revenue to non-GAAP Gross Cash Generated from Customer Contracting Activities ($ in thousands) *fav. - Favorable unfav. - Unfavorable 2016 2015 Amount % Consolidated Statement of Operations Data: RCM services : net operating fees $248,701 $3,610 $
Slide 19: Reconciliation of GAAP net income to non-GAAP Net Cash Generated
©2016 Accretive Health Inc.19 Reconciliation of GAAP net income (loss) to non-GAAP Net Cash Generated from Customer Contracting Activities ($ in thousands) 2016 2015 Amount % Net income (loss ) $167,403 ($30,445) $197,848 fav. Net interest income (84) (5) (79) fav. Income tax provis ion (benefi t) 1
Slide 20: Share-Based Compensation and D&A Expense within Operating Expenses
©2016 Accretive Health Inc.20 Share-Based Compensation and D&A Expense included within Operating Expenses ($ in thousands) 2016 2015 Share-based Compensation Allocation Details Cost of services $2,003 $1,400 Sel l ing, general and adminis trative 4,895 3,796 Total share-based compensation expense $6
Slide 21: Condensed Consolidated non-GAAP Financial Information
©2016 Accretive Health Inc.21 Condensed Consolidated non-GAAP Financial Information ($ in thousands) 1Excludes share-based compensation, depreciation and amortization, and restatement and other costs 2016 2015 GAAP net services revenue $352,193 $10,971 (Decrease) increase in deferred customer bi l l